Author: healthprofessionalradio

Dr. Raymond Douglas, an oculoplastic surgeon, discusses the approval of TEPEZZA™ (teprotumumab-trbw) for the treatment of Thyroid Eye Disease (TED), the first and only FDA-approved medicine for the treatment of TED. The FDA approval of TEPEZZA™ is supported by a robust body of clinical evidence, including statistically significant, positive results from the Phase 2 clinical study, as well as the Phase 3 confirmatory clinical study OPTIC. Dr. Douglas previously presented at the American College of Rheumatology (ACR) 2019 annual meeting, sharing integrated, pooled phase 2/phase 3 clinical study data that further substantiates that teprotumumab improves the debilitating effects of active TED, including proptosis (eye bulging), diplopia (double vision), quality of life (QoL) and clinical activity score (CAS).  He is joined by Wendy a participant in the TEPEZZA™ trial who saw an improvement in her eye bulging among other symptoms.

Dr. Angela Nicholas, M.D., a Fight Colorectal Cancer board member, and advocate discusses new guidelines from the American Cancer Society that has recommended screening as early as age 45 due to evidence of an increase in colorectal cancer in those under 50, and available screening tests which include a noninvasive at-home option called Cologuard for those at average risk.  She also shares her own personal journey with her husband who was diagnosed with stage IV colorectal cancer.

Dr. Tere Linzey, a Licensed Educational Psychologist and founder of BrainMatterZ discusses Brain Optimization and cognitive training that can greatly improve a child’s scholastic performance.

J.G. Jones, a comic book artist, discusses his journey living with a myeloproliferative neoplasm, a type of rare blood cancer, that was diagnosed 10 years ago, and his participation in “Rare Reflections: MPNs Unmasked“, a new campaign sponsored by Incyte which will feature a series of portraits by J.G. of real MPN patients and caregivers. 

Research scientist at Kaiser Permanente Division of Research, Dr. Candyce Kroenke, MPH, ScD, discusses recent research that indicated post-menopausal women with colorectal cancer would die sooner from their disease if they had a lack of support from their families, friends and social networks when they were diagnosed than those who had high levels of support.  This research underscores the importance of identifying patients at risk of low social support and providing them with additional resources, including emotional support and logistical help.

Dr. Paul Martinez, a Critical Care Medicine physician at Nicklaus Children’s Hospital in Miami, FL discusses the clinical perspective on teen vaping.

G.T. LaBorde, CEO of IllumiCare discusses recent data that reveals that for each additional specialist seen, patients will stay about one extra day in the hospital. With the national average for a hospital stay at 4.5 days, according to the Agency for Healthcare Research and Quality, fragmentation of specialties in the inpatient setting may be fostering inefficiencies.

Judy Gaman, an award-winning author, public speaker, and CEO of Executive Medicine of Texas, talks about her upcoming book “Love, Life, & Lucille: Lessons from a Centenarian” (April 2020).

Jude Bond, CEO of Cannaphyll™ Hemp-Infused Topicals, discusses Cannaphyll’s patent-pending  blend of organic phylloceuticals that improves endocannabinoid uptake and delivery. Targeted to active-lifestyle boomers, fitness-enthusiast Gen-Xers, mobility-challenged seniors, high-performance athletes, and chronic pain sufferers, Cannaphyll™ provides more than 1,000mg premium Hemp Extract per 1 ounce, making it more potent than virtually all other OTC hemp-infused topical creams.

Dr. Joe Powers, Chief Strategy Officer at AppliedVR, discusses the collaboration between AppliedVR and the National Cancer Institute, part of the National Institute of Health, to evaluate virtual reality (VR) therapeutics as a solution to help cancer patients suffering from stress and anxiety.